Published in PLoS One on December 20, 2012
Sumo E2 enzyme UBC9 is required for efficient protein quality control in cardiomyocytes. Circ Res (2014) 0.87
Optimising methods for the preservation, capture and identification of ubiquitin chains and ubiquitylated proteins by immunoblotting. Biochem Biophys Res Commun (2015) 0.82
Expanding SUMO and ubiquitin-mediated signaling through hybrid SUMO-ubiquitin chains and their receptors. Cell Cycle (2013) 0.81
Analysis of SUMOylated proteins using SUMO-traps. Sci Rep (2013) 0.80
SUMO, a small, but powerful, regulator of double-strand break repair. Philos Trans R Soc Lond B Biol Sci (2017) 0.78
Hypoxia and Inflammation in Cancer, Focus on HIF and NF-κB. Biomedicines (2017) 0.76
Modification by SUMOylation Controls Both the Transcriptional Activity and the Stability of Delta-Lactoferrin. PLoS One (2015) 0.75
Activation of liver X receptor attenuates lysophosphatidylcholine-induced IL-8 expression in endothelial cells via the NF-κB pathway and SUMOylation. J Cell Mol Med (2016) 0.75
Sumoylation of IkB attenuates NF-kB-induced nitrosative stress at rostral ventrolateral medulla and cardiovascular depression in experimental brain death. J Biomed Sci (2016) 0.75
Novel functions of chromatin-bound IκBα in oncogenic transformation. Br J Cancer (2014) 0.75
Ubiquitin-Conjugating Enzyme 9 Phosphorylation as a Novel Mechanism for Potentiation of the Inflammatory Response. Am J Pathol (2016) 0.75
Downregulation of UBC9 promotes apoptosis of activated human LX-2 hepatic stellate cells by suppressing the canonical NF-κB signaling pathway. PLoS One (2017) 0.75
SUMO and the robustness of cancer. Nat Rev Cancer (2017) 0.75
Methionine adenosyltransferase α2 sumoylation positively regulate Bcl-2 expression in human colon and liver cancer cells. Oncotarget (2015) 0.75
Hypoxia Induced NF-κB. Cells (2016) 0.75
The ubiquitin system. Annu Rev Biochem (1998) 43.36
Shared principles in NF-kappaB signaling. Cell (2008) 20.96
SUMO: a history of modification. Mol Cell (2005) 10.40
Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol (2005) 8.06
Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation. Nat Cell Biol (2009) 6.62
SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell (1998) 6.62
Atypical ubiquitin chains: new molecular signals. 'Protein Modifications: Beyond the Usual Suspects' review series. EMBO Rep (2008) 6.21
Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation. Cell (2009) 5.76
SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J Biol Chem (2000) 4.96
Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway. Nat Cell Biol (2008) 4.68
Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene (2006) 4.62
Quantitative analysis of in vitro ubiquitinated cyclin B1 reveals complex chain topology. Nat Cell Biol (2006) 4.25
SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis. Nature (2011) 4.14
The role of ubiquitin in NF-kappaB regulatory pathways. Annu Rev Biochem (2009) 3.86
The emerging complexity of protein ubiquitination. Biochem Soc Trans (2009) 3.85
SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex. Nature (2011) 3.77
Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell (2003) 3.75
Certain pairs of ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s) synthesize nondegradable forked ubiquitin chains containing all possible isopeptide linkages. J Biol Chem (2007) 3.68
Mechanisms, regulation and consequences of protein SUMOylation. Biochem J (2010) 3.22
SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization. Mol Cell (2002) 2.93
Inducible nuclear expression of newly synthesized I kappa B alpha negatively regulates DNA-binding and transcriptional activities of NF-kappa B. Mol Cell Biol (1995) 2.69
Mass spectrometric analysis of lysine ubiquitylation reveals promiscuity at site level. Mol Cell Proteomics (2010) 2.43
In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy. Mol Cell Proteomics (2007) 2.30
Efficient protection and isolation of ubiquitylated proteins using tandem ubiquitin-binding entities. EMBO Rep (2009) 2.26
Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1. J Biol Chem (1999) 2.18
PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress. Nat Cell Biol (2006) 1.85
Role of IkappaBalpha ubiquitination in signal-induced activation of NFkappaB in vivo. J Biol Chem (1996) 1.82
Mechanism of hypoxia-induced NF-kappaB. Mol Cell Biol (2010) 1.74
betaTrCP-mediated proteolysis of NF-kappaB1 p105 requires phosphorylation of p105 serines 927 and 932. Mol Cell Biol (2003) 1.69
Detection of protein SUMOylation in vivo. Nat Protoc (2009) 1.66
SUMO: regulating the regulator. Cell Div (2006) 1.56
Identification of lysine residues required for signal-induced ubiquitination and degradation of I kappa B-alpha in vivo. Oncogene (1996) 1.30
SUMO and NF-kappaB ties. Cell Mol Life Sci (2007) 1.21
Enzymes catalyzing ubiquitination and proteolytic processing of the p105 precursor of nuclear factor kappaB1. J Biol Chem (1998) 1.17
p53-Ubl fusions as models of ubiquitination, sumoylation and neddylation of p53. Cell Cycle (2008) 1.16
Changes in the ratio of free NEDD8 to ubiquitin triggers NEDDylation by ubiquitin enzymes. Biochem J (2012) 1.15
The ubiquitin E1 enzyme Ube1 mediates NEDD8 activation under diverse stress conditions. Cell Cycle (2012) 1.13
Determinants of small ubiquitin-like modifier 1 (SUMO1) protein specificity, E3 ligase, and SUMO-RanGAP1 binding activities of nucleoporin RanBP2. J Biol Chem (2011) 1.10
Uncovering ubiquitin and ubiquitin-like signaling networks. Chem Rev (2011) 1.06
SUMO1 modification of NF-kappaB2/p100 is essential for stimuli-induced p100 phosphorylation and processing. EMBO Rep (2008) 1.06
NEDD8 overexpression results in neddylation of ubiquitin substrates by the ubiquitin pathway. J Mol Biol (2012) 1.00
Innate link between NF-kappaB activity and ubiquitin-like modifiers. Biochem Soc Trans (2008) 0.93
Adenosine signaling mediates SUMO-1 modification of IkappaBalpha during hypoxia and reoxygenation. J Biol Chem (2009) 0.91
Modulation of Abeta generation by small ubiquitin-like modifiers does not require conjugation to target proteins. Biochem J (2007) 0.90
Isolation of ubiquitylated proteins using tandem ubiquitin-binding entities. Methods Mol Biol (2012) 0.89
The mouse small ubiquitin-like modifier-2 (SUMO-2) inhibits interleukin-12 (IL-12) production in mature dendritic cells by blocking the translocation of the p65 subunit of NFκB into the nucleus. Mol Immunol (2011) 0.85
Role of monoubiquitylation on the control of IκBα degradation and NF-κB activity. PLoS One (2011) 0.84
Ubc9 promotes the stability of Smad4 and the nuclear accumulation of Smad1 in osteoblast-like Saos-2 cells. Bone (2008) 0.83
Strategies to Identify Recognition Signals and Targets of SUMOylation. Biochem Res Int (2012) 0.83
Search for new phenomena in tt events with large missing transverse momentum in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 0.82
OMERO: flexible, model-driven data management for experimental biology. Nat Methods (2012) 3.72
Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP. Proc Natl Acad Sci U S A (2008) 2.64
TMP21 is a presenilin complex component that modulates gamma-secretase but not epsilon-secretase activity. Nature (2006) 2.56
E4F1 is an atypical ubiquitin ligase that modulates p53 effector functions independently of degradation. Cell (2006) 2.50
Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations. J Biol Chem (2005) 2.26
Efficient protection and isolation of ubiquitylated proteins using tandem ubiquitin-binding entities. EMBO Rep (2009) 2.26
Dynamic interplay of the SUMO and ERK pathways in regulating Elk-1 transcriptional activity. Mol Cell (2003) 2.23
FOXO1 regulates L-Selectin and a network of human T cell homing molecules downstream of phosphatidylinositol 3-kinase. J Immunol (2008) 1.97
A proteomic study of SUMO-2 target proteins. J Biol Chem (2004) 1.92
Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation. Biochemistry (2003) 1.70
Detection of protein SUMOylation in vivo. Nat Protoc (2009) 1.66
Ubiquitin-associated domain of Mex67 synchronizes recruitment of the mRNA export machinery with transcription. Proc Natl Acad Sci U S A (2006) 1.54
Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function. Mol Cell Biol (2002) 1.48
Stable activation of phosphatidylinositol 3-kinase in the T cell immunological synapse stimulates Akt signaling to FoxO1 nuclear exclusion and cell growth control. J Immunol (2005) 1.47
SUMO-1 modification alters ADAR1 editing activity. Mol Biol Cell (2005) 1.32
The mRNA nuclear export factor Hpr1 is regulated by Rsp5-mediated ubiquitylation. J Biol Chem (2005) 1.19
Acute dosing of latrepirdine (Dimebon), a possible Alzheimer therapeutic, elevates extracellular amyloid-beta levels in vitro and in vivo. Mol Neurodegener (2009) 1.18
Kaposi's sarcoma-associated herpesvirus protein LANA2 disrupts PML oncogenic domains and inhibits PML-mediated transcriptional repression of the survivin gene. J Virol (2009) 1.17
Presenilin 1 mutations activate gamma 42-secretase but reciprocally inhibit epsilon-secretase cleavage of amyloid precursor protein (APP) and S3-cleavage of notch. J Biol Chem (2002) 1.15
ICOS ligation recruits the p50alpha PI3K regulatory subunit to the immunological synapse. J Immunol (2008) 1.14
Abeta-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Abeta pathology. Neurosci Res (2002) 1.14
The presenilins. Genome Biol (2002) 1.11
SUMO-1 modification of human transcription factor (TF) IID complex subunits: inhibition of TFIID promoter-binding activity through SUMO-1 modification of hsTAF5. J Biol Chem (2005) 1.07
Mutations of NFKBIA, encoding IkappaB alpha, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non-EBV-associated cases. Int J Cancer (2009) 1.05
SUMO and transcriptional repression: dynamic interactions between the MAP kinase and SUMO pathways. Cell Cycle (2003) 1.04
Activation of LKB1-Akt pathway independent of phosphoinositide 3-kinase plays a critical role in the proliferation of hepatocellular carcinoma from nonalcoholic steatohepatitis. Hepatology (2010) 1.03
Doublecortin interacts with the ubiquitin protease DFFRX, which associates with microtubules in neuronal processes. Mol Cell Neurosci (2005) 0.97
The sub-cellular localisation of the potato (Solanum tuberosum L.) carotenoid biosynthetic enzymes, CrtRb2 and PSY2. Protoplasma (2013) 0.97
Random mutagenesis of presenilin-1 identifies novel mutants exclusively generating long amyloid beta-peptides. J Biol Chem (2005) 0.96
Integrative analysis of the ubiquitin proteome isolated using Tandem Ubiquitin Binding Entities (TUBEs). J Proteomics (2011) 0.93
Scavenger receptors mediate the role of SUMO and Ftz-f1 in Drosophila steroidogenesis. PLoS Genet (2013) 0.92
Selective SUMO modification of cAMP-specific phosphodiesterase-4D5 (PDE4D5) regulates the functional consequences of phosphorylation by PKA and ERK. Biochem J (2010) 0.91
SUMO modification of the Ets-related transcription factor ERM inhibits its transcriptional activity. J Biol Chem (2005) 0.90
Sp100 isoform-specific regulation of human adenovirus 5 gene expression. J Virol (2014) 0.89
S-adenosylmethionine regulates dual-specificity mitogen-activated protein kinase phosphatase expression in mouse and human hepatocytes. Hepatology (2010) 0.89
SUMO and Alzheimer's disease. Neuromolecular Med (2013) 0.89
Isolation of ubiquitylated proteins using tandem ubiquitin-binding entities. Methods Mol Biol (2012) 0.89
Covalent modification by SUMO is required for efficient disruption of PML oncogenic domains by Kaposi's sarcoma-associated herpesvirus latent protein LANA2. J Gen Virol (2010) 0.88
SUMOylation promotes PML degradation during encephalomyocarditis virus infection. J Virol (2010) 0.87
Cytosolic proteins regulate alpha-synuclein dissociation from presynaptic membranes. J Biol Chem (2006) 0.87
Rotavirus viroplasm proteins interact with the cellular SUMOylation system: implications for viroplasm-like structure formation. J Virol (2012) 0.86
Alzheimer A beta vaccination of rhesus monkeys (Macaca mulatta). Alzheimer Dis Assoc Disord (2004) 0.86
Dietary composition modulates brain mass and solubilizable Abeta levels in a mouse model of aggressive Alzheimer's amyloid pathology. Mol Neurodegener (2009) 0.85
Human mesenchymal stromal cells modulate T-cell responses through TNF-α-mediated activation of NF-κB. Eur J Immunol (2013) 0.85
Regulation of vaccinia virus E3 protein by small ubiquitin-like modifier proteins. J Virol (2011) 0.85
Targeting the amyloid-β antibody in the brain tissue of a mouse model of Alzheimer's disease. J Control Release (2011) 0.84
Role of monoubiquitylation on the control of IκBα degradation and NF-κB activity. PLoS One (2011) 0.84
Strategies to Identify Recognition Signals and Targets of SUMOylation. Biochem Res Int (2012) 0.83
Gamma-secretase-like cleavages of Notch and beta APP are mutually exclusive in human cells. Biochem Biophys Res Commun (2002) 0.83
Sumoylation modulates the activity of Spalt-like proteins during wing development in Drosophila. J Biol Chem (2010) 0.82
Alzheimer's Abeta vaccination of rhesus monkeys (Macaca mulatta). Mech Ageing Dev (2004) 0.81
Acute NADPH oxidase activation potentiates cerebrovascular permeability response to bradykinin in ischemia-reperfusion. Free Radic Biol Med (2010) 0.81
Analysis of SUMOylated proteins using SUMO-traps. Sci Rep (2013) 0.80
Nucleolar exit of RNF8 and BRCA1 in response to DNA damage. Exp Cell Res (2012) 0.80
Metabolomics: a second-generation platform for crop and food analysis. Bioanalysis (2011) 0.79
Serodiagnosis of mycoses using recombinant antigens. Mycopathologia (2005) 0.79
Alleles at the Nicastrin locus modify presenilin 1- deficiency phenotype. Proc Natl Acad Sci U S A (2002) 0.79
Magnetic isolation of Plasmodium falciparum schizonts iRBCs to generate a high parasitaemia and synchronized in vitro culture. Malar J (2014) 0.78
Oligomerization conditions Mdm2-mediated efficient p53 polyubiquitylation but not its proteasomal degradation. Int J Biochem Cell Biol (2010) 0.78
PI3-kinase and the control of T cell growth and proliferation by FoxOs. Bull Cancer (2006) 0.77
CD36 is significantly correlated with adipophilin in human carotid lesions and inversely correlated with plasma ApoAI. J Biomed Biotechnol (2008) 0.76
Vigilin interacts with signal peptide peptidase. Proteome Sci (2012) 0.76
A cluster of familial Creutzfeldt-Jakob disease mutations recapitulate conserved residues in Doppel: a case of molecular mimicry? FEBS Lett (2002) 0.76
SUMO and ubiquitin modifications during steroid hormone synthesis and function. Biochem Soc Trans (2010) 0.76
Role of p73 in Alzheimer disease: lack of association in mouse models or in human cohorts. Mol Neurodegener (2013) 0.75
[PI3-kinase: Linking immunological synapse to T-cell proliferation]. Med Sci (Paris) (2006) 0.75